hasActiveMetabolite

P97057
predicate

Indicates that a substance produces one or more metabolites that remain pharmacologically active in the body.

Try in SPARQL

All labels observed (4)

Label Occurrences
hasActiveMetabolite canonical 11
hasMetabolite 7
metaboliteOf 2

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasActiveMetabolite
Generated description
Indicates that a substance produces one or more metabolites that remain pharmacologically active in the body.

Sample triples (21)

Subject Object
cyclophosphamide 4-hydroxycyclophosphamide ⓘ
cyclophosphamide phosphoramide mustard ⓘ
Albendazole
linked to: albendazole
albendazole sulfoxide via predicate surface "hasMetabolite" ⓘ
Albendazole
linked to: albendazole
albendazole sulfone via predicate surface "hasMetabolite" ⓘ
Allegra terfenadine via predicate surface "isMetaboliteOf" ⓘ
thioridazine mesoridazine ⓘ
thioridazine sulforidazine ⓘ
norepinephrine 3-methoxy-4-hydroxyphenylglycol via predicate surface "hasMetabolite" ⓘ
norepinephrine MHPG via predicate surface "hasMetabolite" ⓘ
norepinephrine vanillylmandelic acid via predicate surface "hasMetabolite" ⓘ
norepinephrine VMA via predicate surface "hasMetabolite" ⓘ
dihydroartemisinin artemether via predicate surface "metaboliteOf" ⓘ
dihydroartemisinin artesunate via predicate surface "metaboliteOf" ⓘ
irinotecan SN-38 ⓘ
itraconazole hydroxy-itraconazole ⓘ
clarithromycin 14-hydroxyclarithromycin ⓘ
Terfenadine
linked to: terfenadine
fexofenadine ⓘ
Ebastine
linked to: ebastine
carebastine ⓘ
Clobazam
linked to: clobazam
N-desmethylclobazam ⓘ
fenfluramine norfenfluramine via predicate surface "hasMetabolite" ⓘ
acalabrutinib ACP-5862 ⓘ